Ratings by Citi (Ashiq Mubarack)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/15/2023 | Alpha Tau Medical Ltd. | DRTS | New Coverage | Buy (N/A) |
2.81 (6.41) |
128.11% | Details | |
| 12/4/2023 | Mersana | MRSN | Upgrade | Buy (Neutral) |
1.90 (2.63) |
38.42% | Details | |
| 7/27/2023 | Mersana | MRSN | Downgrade | Neutral (Buy) |
3.91 (29.08) |
643.73% | Details | |
| 5/10/2023 | Mersana | MRSN | Maintain | Buy (N/A) |
|
Details | ||
| 1/20/2023 | Mersana | MRSN | Maintain | Buy (N/A) |
|
Details |
